BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 16170384)

  • 21. Prevention of CCl4-induced liver cirrhosis by ribbon antisense to transforming growth factor-beta1.
    Doh KO; Jung HK; Moon IJ; Kang HG; Park JH; Park JG
    Int J Mol Med; 2008 Jan; 21(1):33-9. PubMed ID: 18097613
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synergistic down-regulation of telomerase by all-trans retinoic acid and antisense oligonucleotide in oral squamous cell carcinoma cell line (Tca8113).
    Zhang P; Xu Q; Chen WT; Duan LQ; Zhang ZY; Zhou XJ
    Oral Oncol; 2005 Oct; 41(9):909-15. PubMed ID: 16051514
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipid modification of GRN163, an N3'-->P5' thio-phosphoramidate oligonucleotide, enhances the potency of telomerase inhibition.
    Herbert BS; Gellert GC; Hochreiter A; Pongracz K; Wright WE; Zielinska D; Chin AC; Harley CB; Shay JW; Gryaznov SM
    Oncogene; 2005 Aug; 24(33):5262-8. PubMed ID: 15940257
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Therapeutic effects of hTR-siRNA adenovirus on human cervical cancer xenografts in nude mice].
    Li WY; Li MY; Xiao LY; Zhang CL; Liu YR; Li XY; Zhang SY; Li Y
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 39(5):711-4, 731. PubMed ID: 19024296
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of human telomerase in MKN-45 cell line by antisense hTR expression vector induces cell apoptosis and growth arrest.
    Feng RH; Zhu ZG; Li JF; Liu BY; Yan M; Yin HR; Lin YZ
    World J Gastroenterol; 2002 Jun; 8(3):436-40. PubMed ID: 12046065
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 2-5A antisense telomerase RNA therapy for intracranial malignant gliomas.
    Mukai S; Kondo Y; Koga S; Komata T; Barna BP; Kondo S
    Cancer Res; 2000 Aug; 60(16):4461-7. PubMed ID: 10969793
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between telomerase activity and basic fibroblast growth factor up-regulation in retinoblastomas.
    Kondo Y; Tanaka Y; Shields JA; Kondo S
    Anticancer Res; 2001; 21(6A):3765-72. PubMed ID: 11911245
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of telomerase with human telomerase reverse transcriptase antisense increases the sensitivity of tumor necrosis factor-alpha-induced apoptosis in prostate cancer cells.
    Gao XD; Chen YR
    Asian J Androl; 2007 Sep; 9(5):697-704. PubMed ID: 17712489
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Specific telomere dysfunction induced by GRN163L increases radiation sensitivity in breast cancer cells.
    Gomez-Millan J; Goldblatt EM; Gryaznov SM; Mendonca MS; Herbert BS
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):897-905. PubMed ID: 17175117
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human hepatoma cell telomerase activity inhibition and cell cycle modulation by its RNA component antisense oligodeoxyribonucleotides.
    Zhang RG; Wang XW; Yuan JH; Xie H
    Acta Pharmacol Sin; 2000 Aug; 21(8):742-6. PubMed ID: 11501185
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human telomerase RNA degradation by 2'-5'-linked oligoadenylate antisense chimeras in a cell-free system, cultured tumor cells, and murine xenograft models.
    Paranjape JM; Xu D; Kushner DM; Okicki J; Lindner DJ; Cramer H; Silverman RH; Leaman DW
    Oligonucleotides; 2006; 16(3):225-38. PubMed ID: 16978086
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Construction of antisense human tankyrase-1 RNA retroviral vector and its inhibition on tongue cancer cells].
    Ji YX; Zhang P; Chen WM; Zhu SR; Tao XJ
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2007 Mar; 42(3):180-3. PubMed ID: 17565831
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of telomerase with human telomerase reverse transcriptase antisense enhances tumor necrosis factor-alpha-induced apoptosis in bladder cancer cells.
    Gao XD; Chen YR
    Chin Med J (Engl); 2007 May; 120(9):755-60. PubMed ID: 17531113
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of human telomerase activity by peptide nucleic acids.
    Norton JC; Piatyszek MA; Wright WE; Shay JW; Corey DR
    Nat Biotechnol; 1996 May; 14(5):615-9. PubMed ID: 9630953
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A hexameric phosphorothioate oligonucleotide telomerase inhibitor arrests growth of Burkitt's lymphoma cells in vitro and in vivo.
    Mata JE; Joshi SS; Palen B; Pirruccello SJ; Jackson JD; Elias N; Page TJ; Medlin KL; Iversen PL
    Toxicol Appl Pharmacol; 1997 May; 144(1):189-97. PubMed ID: 9169084
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The efficacy of autocatalytic casapse-3 driven by human telomerase reverse transcriptase promoter on human ovarian carcinoma].
    Song Y; Shen K; Yu JR
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(41):2919-24. PubMed ID: 18261307
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of telomerase activity of melanoma cells in vitro by antisense oligonucleotides.
    Glukhov AI; Zimnik OV; Gordeev SA; Severin SE
    Biochem Biophys Res Commun; 1998 Jul; 248(2):368-71. PubMed ID: 9675142
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo inhibition of lung cancer by GRN163L: a novel human telomerase inhibitor.
    Dikmen ZG; Gellert GC; Jackson S; Gryaznov S; Tressler R; Dogan P; Wright WE; Shay JW
    Cancer Res; 2005 Sep; 65(17):7866-73. PubMed ID: 16140956
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of antisense oligodeoxynucleotides of RNA component of human telomerase on cisplatin induced apoptosis in K562 cells].
    Xiao Y; Zhang H
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Feb; 23(2):144-7. PubMed ID: 12581964
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of telomerase RNA (hTR) in cervical cancer by adenovirus-delivered siRNA.
    Li Y; Li H; Yao G; Li W; Wang F; Jiang Z; Li M
    Cancer Gene Ther; 2007 Aug; 14(8):748-55. PubMed ID: 17479103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.